Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Morten Orebo Holmström*, Guy W. Novotny, Jesper Petersen, Mia Aaboe-Jørgensen, Hans Carl Hasselbalch, Mads H. Andersen, Signe Ledou Nielsen, Daniel El Fassi, Claudia Schöllkopf

*Corresponding author af dette arbejde
2 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftLeukemia and Lymphoma
ISSN1042-8194
DOI
StatusUdgivet - 10 nov. 2019

Citationsformater